Evidence map›Paper›PMID 38786816›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Solvothermally Grown Oriented WO

Mirco Cescon, Claudia Stevanin, Matteo Ardit, Michele Orlandi, Annalisa Martucci, Tatiana Chenet, Luisa Pasti, Stefano Caramori, Vito Cristino

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mirco CesconDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari 46, 44121 Ferrara, Italy.ORCID 0000-0002-1084-1749
Claudia StevaninDepartment of Environmental and Prevention Sciences, University of Ferrara, Via L. Borsari 46, 44121 Ferrara, Italy.
Matteo ArditDepartment of Geosciences, University of Padova, Via Gradenigo 6, 35131 Padova, Italy.ORCID 0000-0001-8998-3063
Michele OrlandiDepartment of Physics, University of Trento, Via Sommarive 14, 38123 Trento, Italy.ORCID 0000-0001-5738-3231
Annalisa MartucciDepartment of Physics and Earth Sciences, University of Ferrara, Via Saragat 1, 44121 Ferrara, Italy.ORCID 0000-0002-6467-881X
Tatiana ChenetDepartment of Environmental and Prevention Sciences, University of Ferrara, Via L. Borsari 46, 44121 Ferrara, Italy.
Luisa PastiDepartment of Environmental and Prevention Sciences, University of Ferrara, Via L. Borsari 46, 44121 Ferrara, Italy.ORCID 0000-0002-2980-3654
Stefano CaramoriDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari 46, 44121 Ferrara, Italy.
Vito CristinoDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari 46, 44121 Ferrara, Italy.

Funding

Ministero dell'Università e della Ricerca 0001052
6 · The paper itself

Abstract

Contamination by pharmaceuticals adversely affects the quality of natural water, causing environmental and health concerns. In this study, target drugs (oxazepam, OZ, 17-α-ethinylestradiol, EE2, and drospirenone, DRO), which have been extensively detected in the effluents of WWTPs over the past decades, were selected. We report here a new photoactive system, operating under visible light, capable of degrading EE2, OZ and DRO in water. The photocatalytic system comprised glass spheres coated with nanostructured, solvothermally treated WO

Indexed as

pharmaceuticalsphotocatalytic prototype systemsolvothermally grown WO3water remediation

Identifiers

PMID38786816
PMCPMC11124514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.